Inflammasomes are cytosolic multi-protein complexes assembled by intracellular nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) and initiate innate immune responses to invading pathogens and danger signals by activating caspase-1^[@R1]^. Caspase-1 activation leads to maturation and release of the proinflammatory cytokines interleukin (IL)-1β and IL-18 as well as a lytic inflammatory cell death termed pyroptosis^[@R2]^. Recently, a novel non-canonical inflammasome was described that activates caspase-11, a proinflammatory caspase required for LPS-induced lethality^[@R3]^. This study also highlighted that previously generated caspase-1 knockout mice lack a functional allele of *Casp-11*, making them functionally *Casp-1/Casp-11* double-knockouts^[@R3]--[@R6]^. Previous studies have shown that these mice are more susceptible to infections with microbial pathogens^[@R1]^, including the bacterial pathogen *Salmonella enterica* serovar Typhimurium (*S.* Typhimurium)^[@R7],[@R8]^, however the individual contributions of caspase-1 and caspase-11 to this phenotype are not known. Here, we show that non-canonical caspase-11 activation contributes to macrophage death during *S*. Typhimurium infection. TLR4/Trif-dependent IFN-β production is crucial for caspase-11 activation in macrophages, but is only partially required for pro-caspase-11 expression, consistent with the existence of an interferon-inducible activator of caspase-11. Finally, *Casp-1^−/−^* mice were significantly more susceptible to infection with *S*. Typhimurium than mice lacking both proinflammatory caspases (*Casp-1^−/−^/Casp-11^−/−^)*. This phenotype was accompanied by higher bacterial counts, the formation of extracellular, bacterial micro-colonies in the infected tissue and a defect in neutrophil-mediated clearance. These surprising results indicate that caspase-11-dependent cell death is detrimental to the host in the absence of caspase-1-mediated innate immunity, resulting in extracellular replication of a facultative intracellular bacterial pathogen.

Previous studies have shown that logarithmic phase *S.* Typhimurium induce a rapid NLRC4-dependent cell death in cultured macrophages that requires the SPI-1 Type 3 Secretion System (T3SS)^[@R9]^. We previously reported that *Salmonella* grown to stationary phase (decreased SPI-1 expression) do not induce rapid activation of NLRC4, but establish themselves in an intracellular niche^[@R10]^. Intracellular *Salmonella* are detected by inflammasome receptors NLRP3 and NLRC4 and mature IL-1β/IL-18 are released 12--17 hours post-infection ([Supplementary Fig. 1 and 2a, b](#SD1){ref-type="supplementary-material"})^[@R10]^. In addition, intracellular *Salmonella* induce an uncharacterized form of lytic cell death that is independent of the SPI-1 T3SS^[@R11]^. To investigate host factors involved in this type of *Salmonella*-induced macrophage death, we infected macrophages deficient for specific inflammasome components with stationary phase wild-type *Salmonella*. Macrophage death, which required infection with live bacteria, did not require NLRP3 or the adaptor protein ASC, but was partially dependent on NLRC4 ([Supplementary Fig. 2a and 3](#SD1){ref-type="supplementary-material"}). Since macrophages from *Casp-1^−/−^/Casp-11^−/−^* mice did not release LDH, we investigated if caspase-1 and caspase-11 were activated and processed in response to intracellular *Salmonella* ([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). Processed caspase-1 p20 and caspase-11 p30 subunits were detected during *Salmonella* infection, indicating that caspase-11 activation correlated with cell death ([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). Consistently, *Casp-11^−/−^* macrophages were significantly more resistant to death than WT macrophages ([Fig. 1a](#F1){ref-type="fig"}), demonstrating an important role for caspase-11 in cell death caused by intracellular *Salmonella*. In contrast to *L. pneumophila* infectons^[@R12]^*,* intracellular growth of *Salmonella* in WT and *Casp-11^−/−^* macrophages was not significantly different (data not shown).

Macrophage death was not totally abrogated in *Casp-11^−/−^* macrophages infected with wild-type *Salmonella*, indicative of an additional cell death pathway ([Fig. 1a](#F1){ref-type="fig"} and [Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"}). Since NLRC4 contributed to macrophage death ([Fig. 1a](#F1){ref-type="fig"} and [Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}), we determined if NLRC4 activation accounted for the remaining cell death seen in *Casp-11^−/−^* macrophages. The second T3SS (SPI-2), which is used by intracellular *Salmonella* to inject effector proteins into the host cell, can also inject flagellin^[@R10]^, a ligand for NLRC4^[@R13]--[@R16]^. Comparable levels of cell death were observed in *Casp-1^−/−^/Casp-11^−/−^* and *Casp-11^−/−^* macrophages infected with a ΔSPI-2 or a Δflagellin strain of *Salmonella* ([Fig. 1a](#F1){ref-type="fig"} and [Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"})*,* suggesting that wild-type *Salmonella* induce cell death through two separate pathways, one controlled by NLRC4 and the other requiring caspase-11.

Finally we compared the levels of cell death in macrophages derived from WT, *Casp-1^−^*^/^ *^−^* Casp-11*^−^*^/^ *^−^*, Casp-11*^−^*^/^ *^−^* or Casp-1*^−^*^/^ *^−^* (Casp-1*^−^*^/^ *^−^*/Casp-11^tg^) mice^[@R3]^ infected with Salmonella. Cell death in *Casp-1^−/−^* macrophages infected with a SPI-2-deficient strain was similar to levels seen in WT macrophages ([Supplementary Fig. 2d](#SD1){ref-type="supplementary-material"}), indicating that *Salmonella* strains that cannot inject flagellin exclusively engage caspase-11-dependent cell death. Consistently, *Casp-11^−/−^* macrophages infected with the ΔSPI-2 strain did not die ([Supplementary Fig. 2d](#SD1){ref-type="supplementary-material"}). In contrast, wild-type *Salmonella* induced cell death via canonical (NLRC4/caspase-1) and non-canonical signaling pathways (caspase-11) ([Supplementary Fig. 1 and 2d](#SD1){ref-type="supplementary-material"}).

NLRP3-mediated cytokine production triggered by non-canonical inflammasome stimuli depends on both caspase-1 and caspase-11^[@R3]^. We therefore investigated if the NLRP3 pathway induced by intracellular *Salmonella* required both caspases. Since IL-1β and IL-18 release in response to intracellular *Salmonella* is exclusively mediated by NLRC4 and NLRP3 ([Supplementary Fig. 2a, b](#SD1){ref-type="supplementary-material"}), we studied the response to SPI-2- or flagellin-deficient *Salmonella*^[@R10]^. Cytokine maturation in response to these strains required both caspase-1 and caspase-11 ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). In contrast, cytokine maturation induced by wild-type *Salmonella*, which activates both NLRP3 and NLRC4, was only partially dependent on caspase-11, but absolutely required caspase-1 ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). These results indicate that intracellular *Salmonella* activate a non-canonical inflammasome similar to LPS/CTB and the enteric bacteria *C. rodentium*, *V. cholerae* and *E. coli*^[@R3]^. Formation of ASC foci (specks), a measure of NLRP3/ASC complex formation, required caspase-11 but not caspase-1 ([Supplementary Fig. 5a, b](#SD1){ref-type="supplementary-material"}), indicating that caspase-11 acts upstream of the NLRP3/ASC complex.

Stimulation of resting macrophages with LPS or IFN-g induces pro-caspase-11 expression^[@R3],[@R4],[@R17]^. To determine whether *Salmonella*-dependent activation of the non-canonical inflammasome was dependent on TLR-mediated recognition, we infected *Tlr4^−/−^* macrophages with flagellin-deficient *Salmonella* (which activate the caspase-11-dependent, non-canonical inflammasome pathway exclusively; [Supplementary Fig. 2 and 4](#SD1){ref-type="supplementary-material"}). Caspase-11 activation, IL-1β secretion, and cell death depended on TLR4 ([Fig. 1b](#F1){ref-type="fig"}). Caspase-11 processing and cell death required the TLR4-dependent signaling adaptor Trif, but not the TLR4-dependent signaling adaptor MyD88 ([Fig. 1c](#F1){ref-type="fig"}). In contrast, IL-1β maturation was reduced in both *MyD88^−/−^* and *Trif^−/−^*, suggesting that cytokine maturation requires both adaptors. Expression of pro-IL-1β required MyD88-signaling ([Supplementary Fig 6a, b](#SD1){ref-type="supplementary-material"}), explaining the lack of mature IL-1β release in *MyD88^−/−^* macrophages ([Fig. 1c](#F1){ref-type="fig"}). Since cytokine production and cell death required Trif, we measured pro-caspase-11 expression in *MyD88^−/−^*, *Trif^−/−^*, and *MyD88^−/−^*/*Trif^−/−^* macrophages infected with *Salmonella*. Although induction of pro-caspase-11 expression was delayed in *MyD88^−/−^* and *Trif^−/−^* macrophages, the levels of pro-caspase-11 protein in *MyD88^−/−^*/*Trif^−/−^* macrophages were significant ([Fig. 1d](#F1){ref-type="fig"} and [Supplementary Fig. 6a](#SD1){ref-type="supplementary-material"}). Thus, pro-caspase-11 protein expression is partially dependent on TLR-signaling. However, other pathways likely contribute. Intriguingly, non-canonical inflammasomes were not activated in *Trif^−/−^* macrophages ([Fig. 1c](#F1){ref-type="fig"}) even though significant amounts of pro-caspase-11 were present. These results indicate that caspase-11 activity requires a Trif-dependent signal.

The adaptor Trif induces NFkB activation and signals through IRF3 to induce the expression of type-I-interferons (type-I-IFNs)^[@R18]^. To investigate if type-I-IFNs could be the Trif-dependent signal required for caspase-11 activation, we compared the levels of IL-1β release, cell death and pro-caspase-11 expression in WT, *Casp-1^−/−^/Casp-11^−/−^* and *IRF3^−/−^* macrophages ([Fig. 2a,b](#F2){ref-type="fig"} and [Supplementary Fig. 6c](#SD1){ref-type="supplementary-material"}). *IRF3^−^*^/^ *^−^* macrophages were significantly impaired in their ability to initiate caspase-11-dependent IL-1β release and cell death even though significant levels of pro-caspase-11 were present, albeit at slightly reduced levels when compared to WT macrophages. To confirm the requirement of type-I-IFN signaling for caspase-11 activation, we measured non-canonical inflammasome activation in macrophages lacking components of type-I and type-II interferon signaling cascade. *IFNαR^−/−^* or *STAT-1^−/−^* macrophages infected with *Salmonella* did not process caspase-11 or induce non-canonical cell death ([Fig. 2c](#F2){ref-type="fig"}), and this was not due to a lack of pro-caspase-11 expression ([Fig. 2d](#F2){ref-type="fig"}). Macrophages lacking *IFNγR* were indistinguishable from WT thereby excluding an involvement of IFN-γ. To confirm a dependency on type-I-IFN signaling for caspase-11 activation, macrophages infected with Δ*flag Salmonella* were treated with recombinant murine IFN-β ([Fig. 2e](#F2){ref-type="fig"}). Consistent with an important role for type-I-IFN in caspase-11 activation, exogenous IFN-β restored cell death and caspase-11 processing in infected *MyD88^−/−^/Trif^−/−^* but not *Casp-1^−/−^/Casp-11^−/−^* macrophages ([Fig. 2e](#F2){ref-type="fig"} and [Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). Importantly, uninfected macrophages treated with IFN-β did not induce LDH release, confirming that IFN-β alone cannot induce non-canonical cell death in the absence of an infection. Our results reveal a previously unreported requirement for type-I-IFN signaling in caspase-11 activation that is consistent with a model in which an interferon inducible activator mediates caspase-11 activation in response to intracellular *Salmonella* ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}).

Finally, to extend our findings to an *in vivo* setting, we infected WT, *Casp-1^−/−^/Casp^−^11^−/−^*, *Casp-1^−/−^ (Casp-1^−/−^/Casp-11^tg^)* and *Casp-11^−/−^* mice orally with wild-type *Salmonella*. As reported previously, *Casp-1^−/−^/Casp-11^−/−^* mice had significantly higher bacterial loads in tissues compared to WT mice ([Fig. 3a](#F3){ref-type="fig"})^[@R7],[@R8]^. Surprisingly, the levels of bacteria in *Casp-1^−/−^* mice were significantly higher compared to *Casp-1^−/−^/Casp-11^−/−^* mice ([Fig. 3a](#F3){ref-type="fig"}). Interestingly, bacterial loads in *Casp-11^−/−^* mice were comparable to WT mice in all organs examined. Unexpectedly, these results imply that activation of proinflammatory caspase-11 is detrimental to the host in the absence of caspase-1. Consistent with these findings, the bacterial loads in *Nlrp3^−/−^/Nlrc4^−/−^* animals, which activate caspase-11, but not caspase-1 in response to *Salmonella* ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}), were significantly higher than in *Casp-1^−/−^/Casp-11^−/−^* mice ([Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}), essentially phenocopying *Casp-1^−/−^*.

Although previous studies have shown that *Casp-1^−/−^/Casp-11^−/−^* mice are more susceptible to many pathogens, the exact mechanism underlying these findings is not well understood^[@R1],[@R19]^. Host defense against systemic *Salmonella* infection requires neutrophils, since *Salmonella* replication in the liver and spleen is exacerbated in neutropenic mice^[@R20],[@R21]^. In addition, *Salmonella* becomes vulnerable to neutrophil-mediated clearance when it transits between host cells^[@R22]^. We therefore investigated if caspase-1 or caspase-11-deficiency resulted in reduced neutrophil influx into the spleen. Splenic neutrophil counts (Ly6G^+^ cells) were reduced in mice lacking either caspase-1 or caspase-11 compared to WT mice, with *Casp-1^−/−^/Casp-11^−/−^* mice having the most significant reduction of neutrophil counts compared to WT animals ([Fig. 3b](#F3){ref-type="fig"}). Since the levels of neutrophils in the mice deficient for caspase-1 or -11 were very similar to each other, and did not correlate with the bacterial loads, we concluded that differences in neutrophil levels alone could not account for the higher bacterial levels in *Casp-1^−/−^* animals ([Fig. 3a](#F3){ref-type="fig"}). We next examined if caspase-1 deficiency resulted in any functional defects in splenic neutrophils. Neutrophils have been previously implicated in phagocytosing and killing extracellular *Salmonella* released by pyroptotic macrophages^[@R22]^. Interestingly, the percentage of neutrophils (Ly6G^+^) among all *Salmonella*-associated cells (Salmo^+^) was significantly reduced in *Casp-1^−/−^* and *Casp-1^−/−^/Casp-11^−/−^* mice compared to WT and *Casp-11^−/−^* mice ([Fig. 3b](#F3){ref-type="fig"}). These data suggested that the lack of caspase-1 resulted in reduced bacterial uptake by neutrophils or reduced association with *Salmonella* during infection. However, since this reduction was observed in both *Casp-1^−/−^* and *Casp-1^−/−^/Casp-11^−/−^* mice, it did not explain the significantly higher CFUs in *Casp-1^−/−^* mice ([Fig. 3a](#F3){ref-type="fig"}).

NLRC4/caspase-1 induced lysis releases intracellular *Salmonella,* thus making them accessible to neutrophil-mediated uptake and killing^[@R22]^. Since both caspase-1 and caspase-11 can induce lysis of infected cells, we speculated that the lack of caspase-11 in *Casp-1^−/−^/Casp-11^−/−^* mice might delay the egress of *Salmonella* from infected macrophages. Consistent with this model, we found that *Salmonella* were present to a higher degree in macrophages in *Casp-1^−/−^/Casp-11^−/−^* mice compared to WT, *Casp-11^−/−^* and *Casp-1^−/−^* mice ([Fig. 3b](#F3){ref-type="fig"}). Gram stain and specific anti-*Salmonella* antibody stainings of tissues revealed that WT and *Casp-11^−/−^* liver sections contained low levels of *Salmonella*, consistent with the CFU data ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). *Casp-1^−/−^/Casp-11^−/−^* liver sections contained high levels of bacteria within cells in the sinusoids ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}), which is consistent with our FACS data indicating that a larger proportion of *Salmonella* are associated with macrophages in these mice ([Fig. 3b](#F3){ref-type="fig"}). *Casp-1^−/−^* liver sections contained mats of extracellular bacteria within typhoid nodules and expanded sinusoids ([Fig. 3c](#F3){ref-type="fig"} and [Supplementary Fig. 9, 10a](#SD1){ref-type="supplementary-material"}). Finally, mice infected with *Salmonella* were injected with the membrane-impermeable antibiotic gentamicin to distinguish intracellular bacteria from extracellular bacteria. Gentamicin treatment significantly reduced bacterial counts in *Casp-1^−/−^* mice, consistent with our histological finding that *Salmonella* is largely extracellular in these mice ([Supplementary Fig. 10b](#SD1){ref-type="supplementary-material"}).

We conclude that caspase-1-deficiency results in reduced neutrophil-mediated clearance of *Salmonella* released from infected macrophages, thus supporting extracellular growth of this facultative intracellular pathogen. In keeping with this observation, it has been reported that *Salmonella* rapidly replicates extracellularly in the liver of neutropenic mice^[@R23]^. This phenotype is alleviated in *Casp-1^−/−^/Casp-11^−/−^* animals, since bacterial egress from the infected macrophages is delayed. Thus, caspase-11-mediated cell death results in detrimental effects to the host in the absence of caspase-1. Our results indicate that the ability of neutrophils to phagocytose bacteria is dependent on a caspase-1-mediated function. Since *Casp-1^−/−^/Casp-11^−/−^*, *IL-1R*^−/−^ or *IL-1β*^−/−^*/IL-18*^−/−^ mice have similar levels of *Salmonella*^[@R8]^, the mechanism is not likely dependent on IL-1β/IL-18 maturation. Future studies are required to identify and characterize this function. Finally, we provide evidence that caspase-11-dependent cell death is exploited by *Salmonella* in the absence of caspase-1 to cause disease in the host, highlighting the need to determine if caspase-11 activation has similar detrimental effects for the host in other infectious disease models.

METHODS SUMMARY {#S1}
===============

Mice {#S2}
----

*Casp-1^−/−^/Casp-11^−/−^* (a.k.a caspase-1 knockout), *Nlrp3^−/−^/Nlrc4^−/−^*, *Casp-11^−/−^* and *Casp-1^−/−^* (*Casp-1^−/−^*/*Casp-11^tg^*) mice were backcrossed to C57BL/6 for at least 10 generations ^[@R3],[@R9],[@R10]^. All mouse studies were approved by the institutional animal care and use committees of Genentech Inc. and Stanford University.

Animal infections {#S3}
-----------------

Mice (fasted for 12 h) were inoculated orogastrically with 2.4×10^7^--1×10^8^ WT or GFP^+^ WT *S.* Typhimurium SL1344. Tissues were harvested at day 4 post-infection, homogenized, and dilutions were plated on LB agar containing 100 μg/ml Streptomycin. Bacterial numbers are expressed as CFU/gram tissue.

Cell culture and infections {#S4}
---------------------------

BMDMs were differentiated as described previously^[@R13]^. *S.* Typhimurium was grown to stationary phase overnight in LB at 37° C with aeration. Cells were infected at an MOI of 100:1 and centrifuged for 15 minutes at 500 g to ensure comparable adhesion of the bacteria to the cells. 100 μg/ml gentamicin was added at 60 min post-infection. Cells were washed at 120 min post-infection followed by addition of 10 μg/ml gentamicin for the remainder of the infection. Recombinant murine IFN-β was added at 2 hours post-infection as indicated.

(Online only) METHODS {#S5}
=====================

Bacterial strains {#S6}
-----------------

Bacterial strains include WT *S.* Typhimurium SL1344, GFP^+^ WT *S.* Typhimurium SL1344 (smo22) and the following *S.* Typhimurium mutants: ΔSPI-2 (ssaV::Kan) and Δflag (fljAB::Kan, fliC::Cm).

Mice {#S7}
----

*Casp-1^−/−^/Casp-11^−/−^* (a.k.a caspase-1 knockout), *Nlrp3^−/−^/Nlrc4^−/−^*, *Casp-11^−/−^* and *Casp-1^−/−^* (*Casp-1^−/−^*/*Casp-11^tg^*) mice were backcrossed to C57BL/6 for at least 10 generations ^[@R3],[@R9],[@R10]^. All mouse studies were approved by the institutional animal care and use committees of Genentech Inc. and Stanford University.

Animal infections {#S8}
-----------------

Mice (fasted for 12 h) were inoculated orogastrically with 2.4×10^7^--1×10^8^ WT or GFP^+^ WT *S.* Typhimurium SL1344. Tissues were harvested at day 4 post-infection, homogenized, and dilutions were plated on LB agar containing 100 μg/ml Streptomycin. Bacterial numbers are expressed as CFU/gram tissue. For *in vivo* gentamicin protection experiments, mice were infected as above and injected intra-peritoneally with 1 mg of gentamicin in 0.2 ml sterile PBS or PBS alone at 48 h, 24 h and 12 h before being euthanized. Bacterial counts were analyzed as above.

Cell culture and infections {#S9}
---------------------------

BMDMs were differentiated as described previously^[@R13]^. *S.* Typhimurium was grown to stationary phase overnight in LB at 37° C with aeration. Cells were infected at an MOI of 100:1 and centrifuged for 15 minutes at 500 g to ensure comparable adhesion of the bacteria to the cells. 100 μg/ml gentamicin was added at 60 min post-infection. Cells were washed at 120 min post-infection followed by addition of 10 μg/ml gentamicin for the remainder of the infection. Recombinant murine IFN-β was added at 2 hours post-infection as indicated.

Histological analysis {#S10}
---------------------

Livers were harvested from infected mice at day 4 post-infection and immediately placed in buffered formalin (R&D). Paraffin embedding, H&E staining and Gram-staining was done by Histo-Tec Lab (Hayward, California). For immunoflurescence paraffin was removed from paraffin-embedded tissue sections with Xylene and graded Ethanol baths. The tissue was stained with rabbit anti-*Salmonella* antibodies and Phalloidin. Tissue was imaged with a Zeiss LSM700 confocal microscope.

FACS analysis {#S11}
-------------

Spleens from infected animals were aseptically removed and crushed between two glass slides in RPMI containing 10 % (v/v) heat-inactivated FBS, 25 mM HEPES, 2 mM L-glutamine, 1 mM sodium pyruvate and 55 μM 2-mercaptoethanol. Single cell suspensions of spleens were obtained by passages through 70 μm filters. Red blood cells were lysed in 175 mM ammonium chloride, 10 mM phosphate buffer, pH 7.0. 2×10^6^ cells were stained per sample. Dead cells were stained using a Live/Dead Fixable dead cell stain kit (Invitrogen). Cells were washed in FACS buffer and rat anti-mouse CD16/CD32 (BD Biosciences) was added to block FcIII/IIR prior to staining with analytical antibodies. Cells were then stained for 30 min on ice with anti-Ly6-G (clone 1A8, BioLegend), anti-F4/80 (eBioscience) and anti-CD11b (BD Biosciences) antibodies. Stained cells were washed twice prior to flow cytometric analysis. Data were collected on a LSR II (BD Biosciences) at the Stanford University shared FACS facility, and the data were analyzed with FlowJo software (Treestar).

Cell culture and infections {#S12}
---------------------------

BMDMs were differentiated in DMEM (Invitrogen) with 10% vol/vol FCS (Thermo Fisher Scientific), 10% MCSF (L929 cell supernatant), 10 mM HEPES (Invitrogen), and nonessential amino acids (Invitrogen). BMDMs were seeded into 6-, 24-, or 96-well plates at a density of 1.25 × 10^6^, 2.5 × 10^5^, or 5 × 10^4^ per well. For all infections *S.* Typhimurium was grown to stationary phase overnight in LB at 37° C with aeration and the BMDMs were infected at an MOI of 100:1. The plates were centrifuged for 15 minutes at 500 g to ensure comparable adhesion of the bacteria to the cells. 100 μg/ml gentamycin (Sigma-Aldrich) was added at 60 min post-infection to kill extracellular bacteria in the cultures. At 120 min post-infection, the cells were washed once with DMEM and given fresh macrophage medium containing 10 μg/ml gentamycin for the remainder of the infection. Recombinant murine IFN-β Sigma was added at 2 hours post-infection when necessary.

Immunofluorescence {#S13}
------------------

BMDMs were seeded onto glass cover slips and infected as described above. Cover slips were fixed with 4% Paraformaldehyde and stained with Rat anti-ASC (Genentech), Rabbit anti-mouse Caspase-1 p10 (Santa Cruz Biotech) and Dapi. Cells were imaged with a Zeiss LSM700 confocal microscope.

Cytokine and LDH release measurement {#S14}
------------------------------------

IL-1β was measured by ELISA (R&D systems). LDH was measured using CytoTox 96 (Non-Radioactive Cytotoxicity Assay, Promega). To normalize for spontaneous lysis, the percentage of LDH release was calculated as follows: ( LDH infected - LDH uninfected / LDH total lysis - LDH uninfected )\*100.

Western blotting {#S15}
----------------

The caspase-1 p10 subunit, caspase-11 p30 and processed IL-1β released into the culture supernatant were determined by Western blotting. Macrophages were washed with plain pre-warmed DMEM lacking serum and phenol red at 6 hours post infection. The cells were then cultured in this DMEM lacking serum and phenol red until 17 hours after infection. The supernatant was collected and precipitated with 10% TCA (vol/vol) for 1 hour on ice. Precipitated proteins were pelleted at 20,000 g for 30 min at 4° C, washed with ice-cold acetone, air-dried, resuspended in SDS-PAGE sample buffer, and heated to 95° C for 10 min. Protein from 2.5×10^6^ macrophages was loaded per well of a 14% acrylamide gel. Western blots were performed with rat anti-mouse caspase-1 antibody (4B4; Genentech) diluted 1:1,000, rat anti-mouse caspase-11 (17D9; Sigma) at 1:500, rabbit anti-IL-18 (Biovision) at 1:500 and goat anti-mouse IL-1β antibody (AF-401-NA; R&D Systems) diluted 1:500. Cell lysates were probed with anti-b-actin antibody (Sigma) at 1:2,000.

Statistical analysis {#S16}
--------------------

Statistical data analysis was done using Prism 5.0a (GraphPad Software, Inc.). Statistical significance was determined by the Mann-Whitney U test or Student's t-test.
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![Signaling through TLR4 and Trif is required for activity of the non-canonical inflammasome pathway\
**a,** LDH release from unprimed BMDMs infected with the indicated *S.* Typhimurium strains for 17 h. **b, c,** IL-1β secretion, LDH release and immunoblots for processed caspase-1, caspase-11, IL-1β and IL-18 released from unprimed BMDMs infected with Δ*flag S.* Typhimurium for 17 h. **d,** Induction of pro-caspase-11 and pro-IL-1β expression in unprimed BMDMs infected with Δ*flag S.* Typhimurium. Graphs show the mean ± s.d. of quadruplicate wells and are representative of three (**a-c**) and two (**d**) independent experiments.](nihms394885f1){#F1}

![Type-I-IFN signaling is required for caspase-11 activation, but not for pro-caspase-11 expression\
**a, c,** IL-1β secretion, LDH release and immunoblots for processed caspase-1, caspase-11 and IL-1β released from unprimed BMDMs infected with Δ*flag S.* Typhimurium for 17 h. **b, d,** Timecourse measuring pro-caspase-11 and pro-IL-1β induction in unprimed BMDMs infected with Δ*flag S.* Typhimurium. **e,** Cell death in BMDMs treated with recombinant murine IFN-β or vehicle control and infected with Δ*flag. S.* Typhimurium for 17 h. Graphs show the mean ± s.d. of quadruplicate wells and are representative of three (**a, c, e**), two (**b, d**) independent experiments.](nihms394885f2){#F2}

![*Casp-1^−/−^* mice are more susceptible to *Salmonella* infection than *Casp-1^−/−^/Casp-11^−/−^* mice\
**a,** Bacterial burden in mice infected orally with GFP^+^ wild-type *S.* Typhimurium at day 4. **b,** Flow-cytometry analysis of neutrophil counts (Ly6G^+^), *Salmonella*-associated neutrophils and the intracellular distribution of *S.* Typhimurium (GFP^+^) in macrophages (F4/80) and neutrophils (Ly6G) in the spleen. **c,** Livers from *S.* Typhimurium-infected mice showing typhoid nodules, mats of extracellular bacteria (stars) and single *Salmonella* (arrowheads). Original magnification 10x or 40x (boxed close-ups). Graphs show ± s.e.m of 6--10 mice per genotype and are representative of two to three independent experiments. \*, *P* \< 0.05, \*\*, *P* \< 0.01. Dashed line: detection limit, UI, Uninfected controls.](nihms394885f3){#F3}
